TAUB REBECCA sold 5.9% of their position (29.10K shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $10.28M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+26.44K
Price / share
$9.45
Trade value
$249.90K
% of position
Common Stock
Shares
−6K
Price / share
$350.19
Trade value
$2.10M
% of position
Common Stock
Shares
−1.90K
Price / share
$351.37
Trade value
$666.55K
% of position
Common Stock
Shares
−2.36K
Price / share
$352.64
Trade value
$831.17K
% of position
Common Stock
Shares
−2.57K
Price / share
$353.82
Trade value
$908.96K
% of position
Common Stock
Shares
−5.80K
Price / share
$354.61
Trade value
$2.06M
% of position
Common Stock
Shares
−6.44K
Price / share
$355.61
Trade value
$2.29M
% of position
Common Stock
Shares
−1.38K
Price / share
$356.52
Trade value
$492K
% of position
Common Stock
Shares
+2.66K
Price / share
$9.45
Trade value
$25.11K
% of position
Common Stock
Shares
−2.06K
Price / share
$350.09
Trade value
$720.14K
% of position
Common Stock
Shares
−600.00
Price / share
$351.50
Trade value
$210.90K
% of position
Net shares
+0.00
Net value
-$10M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/16/2025 | M · Option Exercise | +26.44K | $9.45 | $249.90K | 5.7% | 461.04K | 487.49K |
| Common Stock Direct | 7/16/2025 | S · Sale | −6K | $350.19 | $2.10M | 1.2% | 487.49K | 481.49K |
| Common Stock Direct | 7/16/2025 | S · Sale | −1.90K | $351.37 | $666.55K | 0.4% | 481.49K | 479.59K |
| Common Stock Direct | 7/16/2025 | S · Sale | −2.36K | $352.64 | $831.17K | 0.5% | 479.59K | 477.23K |
| Common Stock Direct | 7/16/2025 | S · Sale | −2.57K | $353.82 | $908.96K | 0.5% | 477.23K | 474.67K |
| Common Stock Direct | 7/16/2025 | S · Sale | −5.80K | $354.61 | $2.06M | 1.2% | 474.67K | 468.87K |
| Common Stock Direct | 7/16/2025 | S · Sale | −6.44K | $355.61 | $2.29M | 1.4% | 468.87K | 462.42K |
| Common Stock Direct | 7/16/2025 | S · Sale | −1.38K | $356.52 | $492K | 0.3% | 462.42K | 461.04K |
| Common Stock Direct | 7/17/2025 | M · Option Exercise | +2.66K | $9.45 | $25.11K | 0.6% | 461.04K | 463.70K |
| Common Stock Direct | 7/17/2025 | S · Sale | −2.06K | $350.09 | $720.14K | 0.4% | 463.70K | 461.64K |
| Common Stock Direct | 7/17/2025 | S · Sale | −600.00 | $351.50 | $210.90K | 0.1% | 461.64K | 461.04K |
| Total | +0.00 | -$10M | ||||||
Stock Option (Right to Buy)
Common Stock
26.44K shares
Shares
−26.44K
Strike price
9.45
Held after
50.12K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
2.66K shares
Shares
−2.66K
Strike price
9.45
Held after
47.46K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock26.44K shares | 7/16/2025 | M · Option Exercise | −26.44K | 9.45 | — | 50.12K |
| Stock Option (Right to Buy) Direct | Common Stock2.66K shares | 7/17/2025 | M · Option Exercise | −2.66K | 9.45 | — | 47.46K |
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 655.54K | Indirect |
| Total | 655.54K | 655.54K indirect |